As of 2025-05-05, the Intrinsic Value of Metacrine, Inc. (MTCR) is -4.49 USD. This MTCR valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.49 USD, the upside of Metacrine, Inc. is -1,006.34%.
Based on its market price of 0.49 USD and our intrinsic valuation, Metacrine, Inc. (MTCR) is overvalued by 1,006.34%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.49 - -4.49 | -4.49 | -1,006.34% |
| P/E | (17.40) - (24.69) | (21.73) | -4491.2% |
| DDM - Stable | (6.60) - (24.03) | (15.32) | -3194.6% |
| DDM - Multi | (9.89) - (28.76) | (14.81) | -3093.0% |
| Market Cap (mil) | 21.07 |
| Beta | 0.20 |
| Outstanding shares (mil) | 42.57 |
| Enterprise Value (mil) | -17.90 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.79% |
| Cost of Debt | 5.00% |
| WACC | 8.65% |